BEQAX
Price
$35.14
Change
+$0.20 (+0.57%)
Updated
Jul 9 closing price
Net Assets
1.72B
VTSAX
Price
$149.69
Change
+$0.95 (+0.64%)
Updated
Jul 9 closing price
Net Assets
1.91T
Interact to see
Advertisement

BEQAX vs VTSAX

Header iconBEQAX vs VTSAX Comparison
Open Charts BEQAX vs VTSAXBanner chart's image
American Century Equity Growth A
Price$35.14
Change+$0.20 (+0.57%)
VolumeN/A
Net Assets1.72B
Vanguard Total Stock Mkt Idx Adm
Price$149.69
Change+$0.95 (+0.64%)
VolumeN/A
Net Assets1.91T
BEQAX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BEQAX vs. VTSAX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEQAX is a StrongBuy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. BEQAX (1.72B). VTSAX pays higher dividends than BEQAX: VTSAX (1.21) vs BEQAX (0.40). BEQAX was incepted earlier than VTSAX: BEQAX (28 years) vs VTSAX (25 years). BEQAX (0.91) is less costly to investors than VTSAX (0.04). BEQAX is a more actively managed with annual turnover of: 53.00 vs. VTSAX (2.00). BEQAX has a lower initial minimum investment than VTSAX: BEQAX (2500) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 12.27 vs. BEQAX (10.66). VTSAX return over 5 years is better than : 90.59 vs. BEQAX (16.53).
BEQAXVTSAXBEQAX / VTSAX
Total Expense Ratio0.910.042,275%
Annual Report Gross Expense Ratio0.910.042,275%
Fund Existence28 years25 years-
Gain YTD4.5105.51582%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.72B1.91T0%
Annual Yield % from dividends0.401.2133%
Returns for 1 year10.6612.2787%
Returns for 3 years45.0857.4578%
Returns for 5 years16.5390.5918%
Returns for 10 years23.17195.0912%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTGX52.292.59
+5.21%
Protagonist Therapeutics
SONN4.640.17
+3.80%
Sonnet BioTherapeutics Holdings Inc
APP352.747.99
+2.32%
Applovin Corp
CNOB24.820.16
+0.65%
ConnectOne Bancorp
ENTA7.13-0.62
-8.00%
Enanta Pharmaceuticals